Clinical Chemistry Analyzers Market Research Report 2023 – Global Forecasts to 2028: Growth Opportunities in Emerging Economies & Increasing Government Initiatives and Funding for Preventive Care – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.


The global clinical chemistry analyzers market size is projected to reach USD 16.5 billion by 2028 from USD 13.0 billion in 2023, at a CAGR of 4.9%

This report provides a comprehensive analysis of major industry players, offering insights into their business profiles, solutions, services, and strategic activities such as contracts, partnerships, agreements, new product launches, mergers, acquisitions, and recent developments within the clinical chemistry analyzers market. Additionally, the report includes a competitive analysis of emerging startups within this market ecosystem.

The clinical chemistry analyzers market is experiencing substantial growth driven by various factors. Key drivers encompass the expanding elderly population and the increasing prevalence of chronic and lifestyle-related diseases. Furthermore, the adoption of Point-of-Care testing devices and the growing demand for laboratory automation are significant contributors to the market’s ongoing expansion.

However, certain challenges, including high capital investment requirements, a shortage of skilled clinical laboratory technicians, and the presence of refurbished products, could temper market growth in the foreseeable future.

The Asia Pacific region is poised to exhibit the highest compound annual growth rate (CAGR) during the forecast period, primarily led by countries like China and Japan. Several factors contribute to the growth of the clinical chemistry analyzers market in this region. The rising elderly population and the escalating burden of chronic diseases create substantial demand for advanced diagnostic solutions. Additionally, improving per capita income and healthcare infrastructure in Asia Pacific countries bolster the adoption of clinical chemistry analyzers.

Key market players are also making significant investments in the healthcare sector, further propelling market growth. The increasing demand for cutting-edge technologies and the expansion of private-sector healthcare facilities into rural areas across various Asia Pacific countries drive market expansion. Moreover, the growing number of hospitals and clinics in the region caters to the healthcare needs of the population, resulting in heightened demand for clinical chemistry analyzers.

This report also offers an in-depth evaluation of market rankings, growth strategies, and service offerings of leading players such as F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), among others in the clinical chemistry analyzers market.

The reagents accounted for the highest growth rate in the clinical chemistry analyzers market, by product, during the forecast period

In the clinical chemistry analyzers market, the segments include analyzers, reagents, and other products. The reagents segment exhibited the highest growth rate in 2022.

This growth can be attributed to the substantial demand for reagents, which are required in larger quantities compared to analyzers. The continuous need for reagents and repeat purchases contribute to the significant market growth of this segment.

Lipid profile tests segment accounted for the highest CAGR

The clinical chemistry analyzers market is categorized based on test types, including basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests. In 2022, the lipid profile tests segment exhibited the highest growth rate.

The growth of this segment can be attributed to the escalating obesity rates globally and the subsequent increase in obesity-related diseases. These factors significantly drive the demand for lipid profile tests, contributing to the robust growth of this segment in the clinical chemistry analyzers market.

Hospitals and clinics segment accounted for the highest CAGR

The clinical chemistry analyzers market is segmented based on end-users, including hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and other end users.

In 2022, the hospitals and clinics segment exhibited the highest growth rate. This growth can be attributed to several factors, such as the global increase in the number of hospitals due to the rising incidences of diseases and disorders. Additionally, the growing adoption of analyzers in hospital and clinic settings, coupled with advancements in technology, has contributed to the significant growth of this segment in the clinical chemistry analyzers market.

Premium Insights

Rising Adoption of Poc Products to Support Market Growth During Forecast Period

Reagents Segment to Dominate Market During Forecast Period

Basic Metabolic Panel Segment to Hold Largest Share During Forecast Period

Hospitals & Clinics Segment to Continue to Dominate Market During Forecast Period

Asia-Pacific Market Expected to Grow at Highest CAGR During Forecast Period

Market Dynamics

Drivers

Rising Geriatric Population and Increasing Prevalence of Chronic & Lifestyle Diseases

Growing Adoption of Point-Of-Care Testing Devices

Increasing Demand for Laboratory Automation

Restraints

Requirement for High Capital Investments and Shortage of Skilled Laboratory Technicians

Availability of Refurbished Analyzers

Opportunities

Increasing Government Initiatives and Funding for Preventive Care

Growth Opportunities in Emerging Economies

Challenges

Increasing Regulatory Requirements

High Degree of Consolidation

Company Profiles

Key Players

F. Hoffmann-La Roche Ltd.

Danaher Corporation

Abbott Laboratories

Siemens Healthcare GmbH

Thermo Fisher Scientific Inc.

Horiba, Ltd.

Sysmex Corporation

Ekf Diagnostics

Quidelortho Corporation

Hitachi Ltd.

Other Players

Mindray Medical International Ltd.

Elitech Group

Biobase Group

Sfri

Trivitron Healthcare Pvt. Ltd.

Randox Laboratories Ltd.

Medica Corporation

Meril Life Sciences Pvt. Ltd.

Erba Mannheim

Genrui Biotech Co. Ltd.

Dirui

Teco Diagnostics

Balio Diagnostics

Snibe Co. Ltd.

Ams Alliance

For more information about this report visit https://www.researchandmarkets.com/r/j6ql4r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.